Article
TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
Cancer genetics and cytogenetics - 1 Jan 2008
Lima-Ramos Vítor, Pacheco-Figueiredo Luís, Costa Sandra, Pardal Fernando, Silva Ana, Amorim Júlia, Lopes José Manuel, Reis Rui Manuel
Abstract excerpt
TP53 is a key tumor suppressor gene that encodes a transcriptional factor involved in several cellular mechanisms, including growth arrest, DNA repair, and induction of apoptosis. In addition to TP53 gene mutations, a common polymorphism, Arg72Pro, has been involved in the carcinogenesis process. The Pro72 variant has been associated with a slower induction of apoptosis and may influence the risk of cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
